Gardiner, B.J., Chow, J.K., Price, L.L., Nierenberg, N.E., Kent, D.M. and Snydman, D.R. (2017) Role of Secondary Prophylaxis with Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients. Clinical Infectious Diseases, 65, 2000-2007.
https://doi.org/10.1093/cid/cix696

has been cited by the following article:

• TITLE: The Troll in Transplant—CMV Esophagitis in a Post Orthotopic Liver Transplant Patient Complicated with Scalp Squamous Cell Carcinoma

  AUTHORS: Alif Adlan Mohd Thabit, Anuradha Radhakrishnan, Haniza Omar, Tan Soek Siam

  KEYWORDS: Orthotopic Liver Transplant, Cytomegalovirus CMV, Esophagitis, Limited Systemic Sclerosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.11 No.4, April 19, 2022

  ABSTRACT: A liver transplant candidate who is CMV serostatus positive and is subjected to calcineurin inhibitor such as tacrolimus post transplant may increase risk of CMV disease, and may promote tumor progression in some. We report a case of a late localized CMV disease manifesting as oesophagitis after 7 years post orthotopic liver transplantation complicated with an aggressive scalp squamous cell carcinoma which recurred despite wide local excision procedure. Hence it is crucial to modulate the patient’s risk factors for tumor progression without compromising the patient to graft rejection.